Feng Jiayu, Zhang Yuhui, Zhang Jian
State Key Laboratory of Cardiovascular Disease, Heart Failure Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Key Laboratory of Clinical Research for Cardiovascular Medications, National Health Committee, Beijing, China.
JACC Asia. 2024 Mar 19;4(4):249-264. doi: 10.1016/j.jacasi.2024.01.013. eCollection 2024 Apr.
Heart failure (HF) represents a complex clinical syndrome affecting multiple organs and systems of the body, which is a global public health concern because of its high prevalence, mortality, and medical cost. Asia, with its vast population, diverse ethnicities, and complex health care systems, faces challenges in the prevention and management of HF. However, unlike in Western nations, data on HF epidemiology is still limited in Asia. In this review, we will summarize available information regarding the burden of HF in Asia from the aspects of occurrence, etiology and risk factors, outcome, and management of HF, to provide insights for reducing the burden of HF and improving the prognosis of patients with HF.
心力衰竭（HF）是一种影响身体多个器官和系统的复杂临床综合征，由于其高患病率、高死亡率和高昂的医疗成本，已成为全球公共卫生问题。亚洲人口众多、种族多样且医疗保健系统复杂，在心力衰竭的预防和管理方面面临挑战。然而，与西方国家不同，亚洲关于心力衰竭流行病学的数据仍然有限。在本综述中，我们将从心力衰竭的发生、病因和危险因素、结局以及管理等方面总结亚洲心力衰竭负担的现有信息，为减轻心力衰竭负担和改善心力衰竭患者的预后提供见解。
